132 Participants Needed

Ibuprofen + Dexamethasone for Lower Back Pain

Recruiting at 3 trial locations
EI
Overseen ByEddie Irizarry, MD
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 6 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the effectiveness of combining ibuprofen and dexamethasone (a corticosteroid) for individuals with sudden lower back pain that radiates pain or tingling to their legs. It compares this treatment to a placebo to determine which provides better pain relief. Participants will also receive a brief educational session on managing back pain. This trial suits individuals who have experienced less than two weeks of back pain affecting daily activities and have not had frequent back pain in the past three months. Participants should not have had a recent back injury and must be able to return home after their hospital visit. As a Phase 4 trial, this research aims to understand how this already FDA-approved and effective treatment can benefit more patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use pain medication daily or have chronic steroid use. It's best to discuss your specific medications with the trial team.

What is the safety track record for these treatments?

A previous study showed that common pain relievers like ibuprofen, known as NSAIDs (non-steroidal anti-inflammatory drugs), help reduce pain and disability in people with low back pain. The relief was modest but noticeable. Research also shows that combining ibuprofen with dexamethasone, a type of steroid, can be effective for short-term pain relief. However, some studies suggest that dexamethasone might lead to longer-lasting pain in certain cases.

Ibuprofen is well-known and generally safe when used as directed. Dexamethasone is also widely used but can sometimes cause side effects like increased blood sugar or mood changes. In this trial, both medications are given at standard doses and for a short time, which usually limits the risk of serious side effects.

Overall, these treatments are generally well-tolerated, but like any medication, there can be risks. Participants should ask questions and discuss any concerns with the trial team.12345

Why are researchers enthusiastic about this study treatment?

Researchers are excited about combining ibuprofen with dexamethasone for lower back pain because this approach could offer faster and more effective relief than using ibuprofen alone. While ibuprofen is commonly used for its anti-inflammatory properties, adding dexamethasone, a powerful steroid, may enhance pain relief by further reducing inflammation quickly. Additionally, the treatment includes a 15-minute educational intervention, which could improve patient understanding and management of their condition, potentially leading to better outcomes. This combination aims to address pain and inflammation more comprehensively, offering a potentially superior alternative to standard care options like non-steroidal anti-inflammatory drugs (NSAIDs) alone.

What evidence suggests that this trial's treatments could be effective for lower back pain?

In this trial, participants will receive either a combination of ibuprofen and dexamethasone or ibuprofen with a placebo, along with an educational intervention. Research has shown that using ibuprofen with dexamethasone can help manage lower back pain. For example, a study with 160 patients who underwent back surgery found that dexamethasone significantly reduced pain during movement compared to a placebo (a pill with no active medicine). Ibuprofen, a common pain reliever, has also been proven in several studies to reduce pain more effectively than a placebo. This combination targets both inflammation and pain, potentially offering better relief for sudden lower back pain than ibuprofen alone.12367

Who Is on the Research Team?

EI

Eddie Irizarry, MD

Principal Investigator

Montefiore Medical Center

Are You a Good Fit for This Trial?

This trial is for adults aged 18-70 with acute radicular low back pain, which hasn't lasted more than two weeks and radiates from the lower back to the leg. Participants should have a significant level of disability due to their pain but can't have had frequent back pain in the past three months or direct trauma recently. They must not be pregnant, suffer from chronic pain syndromes, or have conditions that make ibuprofen or dexamethasone risky.

Inclusion Criteria

My pain has lasted less than 2 weeks.
My back pain is not due to a recent injury.
I have severe lower back pain that spreads to my buttock or leg.
See 3 more

Exclusion Criteria

Pregnant
You will be excluded from the study if you have: 1) Stomach ulcers, ongoing stomach discomfort, or history of stomach bleeding 2) Severe heart failure 3) Chronic kidney disease 4) Taking anti-coagulants 5) Liver disease or hepatitis with specific liver enzyme levels.
I take pain medication almost every day for chronic pain.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 day
1 visit (in-person)

Treatment

Participants receive an oral dose of dexamethasone or placebo for 2 consecutive days and a 7-day supply of ibuprofen, along with a low back pain education session

7 days
1 visit (in-person), 2 follow-up calls

Follow-up

Participants are monitored for safety and effectiveness after treatment via telephone follow-ups

7 days
2 follow-up calls

What Are the Treatments Tested in This Trial?

Interventions

  • Dexamethasone Oral
  • Educational Intervention
  • Ibuprofen 400 mg
Trial Overview The study tests if adding dexamethasone to standard care (ibuprofen and education on low back pain) helps improve outcomes for acute radicular low back pain when given during an emergency department visit. Patients are randomly assigned to receive either dexamethasone or a placebo alongside ibuprofen, without knowing which one they're getting.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ibuprofen + dexamethasone + educational interventionExperimental Treatment3 Interventions
Group II: Ibuprofen + placebo + educational interventionPlacebo Group2 Interventions

Ibuprofen 400 mg is already approved in United States, European Union, Canada, Japan, China, Switzerland for the following indications:

🇺🇸
Approved in United States as Ibuprofen for:
🇪🇺
Approved in European Union as Ibuprofen for:
🇨🇦
Approved in Canada as Ibuprofen for:
🇯🇵
Approved in Japan as Ibuprofen for:
🇨🇳
Approved in China as Ibuprofen for:
🇨🇭
Approved in Switzerland as Ibuprofen for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

Published Research Related to This Trial

In treating osteo-articular pathologies, particularly vertebral issues, ibuprofen (Brufen 400) shows a significant and rapid positive effect in 75% of cases when administered at a sufficient dosage of 1,600 mg to 2,400 mg per day.
The study indicates that the tolerance for ibuprofen at these dosages is quite satisfactory, suggesting it is a safe option for managing pain in these conditions.
[Ibuprofen in osteo-articular (author's transl)].Maigne, R., Le Corre, F., Juvin, P., et al.[2013]
In a study of 160 patients undergoing lumbar disk surgery, preoperative dexamethasone significantly reduced acute pain during mobilization compared to placebo, with a notable decrease in pain scores (33 mm vs 43 mm on a visual analog scale).
Dexamethasone also reduced the incidence of postoperative vomiting (17 episodes vs 51 episodes in the placebo group), indicating its potential benefits in managing acute postoperative symptoms.
Preoperative dexamethasone reduces acute but not sustained pain after lumbar disk surgery: a randomized, blinded, placebo-controlled trial.Nielsen, RV., Siegel, H., Fomsgaard, JS., et al.[2022]
In a study involving 37 patients with chronic back pain, naproxen sodium (550 mg twice daily) was found to be significantly more effective than placebo in reducing overall pain, night pain, and pain during movement over a 14-day treatment period.
Diflunisal (500 mg twice daily) did not show significant pain relief compared to placebo, indicating that naproxen sodium may be a more effective option for managing chronic back pain.
Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain.Berry, H., Bloom, B., Hamilton, EB., et al.[2019]

Citations

Non‐steroidal anti‐inflammatory drugs for chronic low back painSix of the 13 included RCTs showed that NSAIDs are more effective than placebo regarding pain intensity. NSAIDs are slightly more effective than placebo ...
Study Details | Ibuprofen With or Without Dexamethasone ...An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of ...
Ibuprofen + Dexamethasone for Lower Back PainIn a study of 160 patients undergoing lumbar disk surgery, preoperative dexamethasone significantly reduced acute pain during mobilization compared to placebo, ...
Anti-inflammatory Medications Raise Risk of Chronic Back ...The study surprisingly shows that the body may need inflammation to prevent acute, short-term pain from turning into chronic pain.
systematic review and network meta-analysisOur study used a network meta-analysis to evaluate the comparative effectiveness of analgesic medicines for adults with acute non-specific low back pain.
Non‐steroidal anti‐inflammatory drugs for low back pain - PMCThe evidence from the 65 trials included in this review suggests that NSAIDs are effective for short‐term symptomatic relief in patients with acute and chronic ...
Common Medications Can Prolong Back Pain, Study SaysWhen they blocked the animals' immune response with dexamethasone, a steroid commonly used to treat back pain, the pain became chronic. Then, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security